Dermatitis News

Wet wrap therapy was beneficial as an acute intervention for children with moderate-to-severe atopic dermatitis in whom other therapies have failed, according to researchers.

Increased platelet activation markers in patients with chronic urticaria may contribute to inflammation, with aspirin suppressing the markers in patients who could tolerate it, according to recent study data.

Pediatric patients with atopic dermatitis had lower levels of arginase activity in their granulocytes and plasma when compared with matched controls, according to recent study results.

Pediatric patients with atopic dermatitis were more likely to experience hypogammaglobulinemia compared with healthy children, according to recent study results.

Higher maternal intake of total dairy products, cheese, yogurt and calcium during pregnancy was associated with a reduced risk for infantile eczema, asthma and atopic eczema in children, according to study results.

Actigraphy was shown to be a convenient tool for assessing sleep disturbances in children with atopic dermatitis, according to study findings.

Patients with moderate-to-severe atopic dermatitis treated with dupilumab as monotherapy and in combination with topical glucocorticoids displayed marked improvement in symptoms, according to recent study results.

Children with asthma and associated atopic dermatitis and allergic rhinitis showed reduced lung function from birth that was not driven by allergic sensitization, according to recent study results.

In recent months, the FDA has approved three sublingual oral immunotherapy tablets for treating grass and ragweed allergies, as well as omalizumab for chronic idiopathic urticaria.

Recent research developments in atopic dermatitis and eczema have included associations with infections, food allergens and asthma. Here are highlights of the results of six studies presented in Healio Allergy/Immunology: